NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-126-2001-0-US-07 Human Papilloma Virus Immunoreactive Peptides US DIV 11/685,632 7507538 Abandoned PDF
NIAID E-293-2008-0-US-01 Human Monoclonal Antibodies Against Influenza A H5 Hemagglutinin For Prevention And Treatment Of H5N1 Infection US 60/894,612 Abandoned
CC E-314-2006-0-US-02 VIRTUAL COLONOSCOPY VIA WAVELETS US ORD 11/685,127 8023710 Issued PDF
NCI E-142-2007-0-US-01 A MicroRNA Expression Profile That Correlates With Androgen Responsiveness In Prostrate Cancer US 60/906,742 Abandoned
NIAID E-142-2006-2-PCT-01 WNV DNA Vaccine Incorporating A CMV/R Backbone And Expressing WNV PRM And E Proteins PCT PCT COMB PCT/US2007/006068 Expired
NIDCR E-131-1998-0-US-33 Thymosin B4 Promotes Wound Repair US CON 11/715,997 Abandoned
NCI E-162-2006-0-US-01 Molecular Probes Fore In Situ Tagging And Isolation Of Membrane Proteins US 60/906,166 Abandoned
NICHD E-153-2007-0-US-01 Nitroxide Radical As A Treatment For Neurodegeneration US 60/894,134 Abandoned
NIDCR E-298-2004-0-US-03 Transcytosis Of Adeno-associated Viruses US National Stage 11/574,954 Abandoned
NIDDK E-248-2004-0-JP-08 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS JP National Stage 2007-531262 Abandoned
NINDS E-153-2005-1-US-01 TREATMENT AND PREVENTION OF INFLAMMATION US 60/905,741 Abandoned
NIDDK E-109-2006-0-AU-03 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient AU National Stage 2007348394 Issued
NIDDK E-109-2006-0-DE-10 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient DE EP 07715531.5 Issued
NIDDK E-109-2006-0-CH-09 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient CH EP 07715531.5 Issued
NIDDK E-109-2006-0-FR-11 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient FR EP 07715531.5 Issued
NIDDK E-109-2006-0-GB-12 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient GB EP 07715531.5 Issued
NIDDK E-109-2006-0-EP-05 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient EP National Stage 07715531.5 Issued
NCI E-307-2004-1-US-01 O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INACTIVATORS AND BETA-GLUCURONIDASE CLEAVABLE PRODRUGS US CIP 11/683,310 7825096 Abandoned PDF
NIDDK E-109-2006-0-CN-08 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient CN National Stage 200780052031.X Issued
NCI E-200-2001-0-US-03 Agents that Bind To And Inhibit Human Cytochrome [P450 2C19] US DIV 11/683,229 7682800 Expired PDF
NIDDK E-109-2006-0-PCT-01 Adenosine Derivatives, Method For The Synthesis Thereof, And The Pharmaceutical Compositions For The Prevention And Treatment Of The Inflammatory Diseases Containing The Same As An Active Ingredient PCT PCT PCT/KR2007/001131 Expired
NCI E-132-2007-1-US-01 The Combination Of HA22 (CAT-8015) With Standard Chemotherapeutic Agents On A Human Burkitt Lymphoma Cell Line US 60/893,596 Abandoned
NIDDK E-248-2004-0-US-09 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS US National Stage 11/574,779 7825126 Abandoned PDF
NINDS E-085-2006-0-PCT-02 REAL-TIME SHIMMING OF RESPIRATION INDUCED POLARIZING MAGNETIC FIELD CHANGES PCT PCT PCT/US2007/005826 Abandoned
NCI E-090-2006-0-PCT-02 Immunotherapy With Natural Killer Cells Expanded Ex Vivo After Nonmyeloablative Lymphodepleting Chemotherapy PCT PCT PCT/US2007/063352 Expired
NIEHS E-057-2005-0-PCT-02 Glycated Peptides And Methods Of Use PCT PCT PCT/US2007/63385 Expired
NCI E-090-2006-0-EP-05 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer EP National Stage 07757951.4 Abandoned
NIDA E-025-2007-0-US-01 TREATMENT OF COCAINE-INDUCED FETAL BRAIN INJURY US 60/893,218 Abandoned
NCI E-090-2006-0-CA-04 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer CA National Stage 2645042 Abandoned
NCI E-090-2006-0-AU-03 Autologous Natural Killer Cells And Lymphodepleting Chemotherapy For The Treatment Of Cancer AU National Stage 2007223093 Abandoned
CC E-170-2004-0-DE-05 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy DE EP 05807519.3 Expired
CC E-170-2004-0-FR-06 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy FR EP 05807519.3 Expired
CC E-170-2004-0-CH-04 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy CH EP 05807519.3 Expired
CC E-170-2004-0-IE-07 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy IE EP 05807519.3 Expired
NCI E-132-2006-2-PCT-01 MATERIALS AND METHODS DIRECTED TO ASPARAGINE SYNTHETASE AND ASPARAGINASE THERAPIES PCT PCT COMB PCT/US2007/005555 Expired
NHLBI E-114-2007-0-US-01 Optical Slice Motion Tracker US 60/904,683 Abandoned
NCI E-132-2007-0-US-01 The Combination Of HA22 (CAT-8015) With Standard Chemotherapeutic Agents On A Human Burkitt Lymphoma Cell Line US 60/892,819 Abandoned
NIBIB E-098-2005-0-US-02 Systems and Methods for Organ Assessment US ORD 11/713,270 Abandoned
NIDCR E-035-2010-2-US-02 INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS US National Stage 11/574,581 7732126 Expired PDF
NCI E-074-2007-0-US-01 The Use Of Human T-box Transcription Factor Brachyury As A Target For Cancer Imrnunotherapy And The Identification Of Epitopes Of Human Brachyury As Targets For Tcell Mediated Lysis Of Tumors US 60/904,236 Abandoned
NHLBI E-276-2004-2-US-06 Methods for Assessing Atherosclerosis by Measuring Expression of FOS or DUSP1 In Monocytes US National Stage 11/661,714 7998682 Issued PDF
NIDA E-134-2006-0-AR-03 Method for decreasing the toxic effects of nicotine on fetuses in pregnant women. AR ORD 20070100813 Abandoned
NCI E-120-2007-0-US-01 Mesothelin Expression In Human Lung Cancer US 60/891,923 Abandoned
NIDDK E-199-2007-0-US-01 Single Electrode Electrochemical/Electrospray Ionization Corona Discharge Electrochemical Electrospray Ionization US 60/903,772 Abandoned
NCI E-084-2007-0-US-01 The Use Of Histone Deacetylase (HDAC) Inhibitors For The Prevention And Cure Of Breast Cancer Brain Metastasis US 60/891,856 Abandoned
NCI E-086-2007-0-US-01 Radiolabeling Of Affibody Molecules With F-18 US 60/891,875 Abandoned
NIAID E-337-2004-0-US-08 Recombinant MVA Viruses Expressing Clade A/G And Clade B Modified HIV Env, Gag, And Pol Genes US National Stage 11/574,285 9453239 Issued PDF
NIAID E-337-2004-0-CA-04 Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes CA National Stage 2578403 Expired
NCI E-233-2004-0-US-03 A COMMENSAL STRAIN OF E. COLI ENCODING AN HIV GP41 PROTEIN (Issued)
Live Microbial Microbiocides (as filed) 		US CON 11/710,512 8349586 Expired PDF
NIDA E-134-2006-0-US-02 Methods for decreasing the toxicity effects of nicotine on fetuses in pregnant women US National Stage 11/679,022 7547712 Abandoned PDF